Streetbeat News

Stock Prices

CLSD

Clearside Biomedical's investigational drug CLS-AX for wet AMD achieved primary and secondary goals in a Phase 2b trial, showing stable visual acuity and anatomy with a well-tolerated safety profile. The trial results support the design of a planned Phase 3 program.

Portfolio Pulse from Vandana Singh

October 09, 2024 | 2:22 pm

BYU

BAIYU Holdings shares experienced a trading halt due to a circuit breaker triggered by an upside movement. Despite this, the stock is currently down by 15.8%.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:21 pm

NCTY

The9 Limited's shares are rising following the announcement of a joint venture between its subsidiary and ShaoXing TongZe Network Technology, a Chinese AI and big data marketing service provider.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:18 pm

NIO

NIO Inc's stock has dropped 10% this week due to volatility in Chinese stocks, driven by disappointment over the lack of aggressive fiscal stimulus from Beijing. The Hang Seng Index's significant drop has raised concerns about consumer demand for electric vehicles in China, a key market for NIO.

Portfolio Pulse from Henry Khederian

October 09, 2024 | 2:17 pm

TSLA

Unusual options activity has been detected for Tesla (NASDAQ:TSLA), with a significant amount of money being spent on both bullish and bearish positions. The options trades are split between 51% bullish and 40% bearish, with a focus on a price range between $5.0 and $540.0. Analysts have mixed ratings on Tesla, with price targets ranging from $236 to $245.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:17 pm

BKNG

Unusual options activity for Booking Holdings (NASDAQ:BKNG) shows a bullish stance among investors, with 36% of trades being bullish. The stock is currently trading at $4257.69, up 0.58%. Analysts have mixed ratings, with price targets ranging from $3590 to $4500.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:17 pm

CRM

Salesforce (NYSE:CRM) has seen significant options market activity, with a notable bearish sentiment among large investors. Benzinga's options scanner identified 8 unusual trades, with 25% bullish and 50% bearish sentiment. The trades suggest a price target range of $250 to $340. Salesforce's stock is currently down 1.09% at $288.39, with RSI indicators suggesting it may be overbought.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:17 pm

CRLBF

MSOS

Charlie Bachtell delivered a keynote at Benzinga's Cannabis Capital Conference, which could impact companies like Cresco Labs (CRLBF) and the AdvisorShares Pure US Cannabis ETF (MSOS).

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:16 pm

AFRM

HD

LUV

NCLH

RJF

Top Wall Street analysts have upgraded their ratings for several companies, including The Home Depot, Raymond James Financial, Southwest Airlines, Affirm Holdings, and Norwegian Cruise Line Holdings. These upgrades reflect increased confidence in the companies' future performance.

Portfolio Pulse from Avi Kapoor

October 09, 2024 | 2:14 pm

ALCE

BNZI

BYU

HELE

IKT

MNTS

SPGC

U.S. stocks showed mixed performance with the Dow Jones rising over 100 points. Helen Of Troy reported better-than-expected Q2 results, while several companies like Momentus Inc. and Banzai International saw significant stock price increases due to positive announcements. Conversely, Sacks Parente Golf and others experienced declines.

Portfolio Pulse from Avi Kapoor

October 09, 2024 | 2:14 pm